Delivery Order SPE2DB22D2006-SPE2DB25FV6LV
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,838.27, is for the supply of Olmesartan-HCTZ 40-25 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,545.60, is a delivery order for the supply of Olmesartan-HCTZ 40-12.5 mg tablets. The contract has an ultimate completion date of July 25, 2024 and utilizes a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,945.39, is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets in 90-count packages. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is a firm-fixed-price delivery order with a performance period...
This is a $1,418.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets in 30-count packages. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,141.20, is for the delivery of Olmesartan-HCTZ 40-25 mg tablets in quantities of 30. It is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $8,434.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Olmesartan-HCTZ 40-12.5 mg tablets, a cardiovascular medication, and has an ultimate completion date of January 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of Olmesartan-HCTZ 40-12.5 mg tablets in 90-count bottles, with a ceiling value of $24,940.04 and a period of performance through October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Olmesartan-HCTZ 20-12.5 mg tablets in quantities of 90 per bottle. The contract has a ceiling value of $1,967.40 and an ultimate completion date of July 11, 2024. This contract award is not associated with a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, provides for the delivery of Olmesartan-HCTZ 40-25 mg tablets to the U.S. government. The $1,728.94 firm-fixed price Delivery Order contract, placed under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, supports the agency's mission to provide logistics, acquisition, and technical services to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,209.53, is for the delivery of Olmesartan-HCTZ 20-12.5 mg tablets in 90-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 25, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger...